Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $251.61 | 2 | 50.4% |
| Food and Beverage | $231.29 | 6 | 46.3% |
| Education | $16.82 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $464.10 | 7 | $0 (2023) |
| TherapeuticsMD, Inc. | $18.80 | 1 | $0 (2019) |
| CSL Behring | $16.82 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $464.10 | 7 | Medtronic, Inc. ($464.10) |
| 2019 | $35.62 | 2 | TherapeuticsMD, Inc. ($18.80) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $149.17 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/20/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/19/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/18/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $234.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/18/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Travel and Lodging | In-kind items and services | $17.61 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/17/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Interventional Lung Solutions | ||||||
| 07/24/2019 | CSL Behring | Zemaira (Biological) | Education | In-kind items and services | $16.82 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/27/2019 | TherapeuticsMD, Inc. | IMVEXXY (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: OBSTETRICSGYNECOLOGY WOMEN'S HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 837 | 1,013 | $161,036 | $45,220 |
| 2022 | 8 | 952 | 1,075 | $158,594 | $44,956 |
| 2021 | 11 | 697 | 810 | $153,294 | $41,464 |
| 2020 | 14 | 946 | 1,030 | $167,194 | $39,548 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 358 | $74,469 | $24,284 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $23,762 | $7,725 | 32.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 44 | $33,364 | $7,076 | 21.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 25 | $8,865 | $2,269 | 25.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 161 | 163 | $7,172 | $1,455 | 20.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 166 | 168 | $7,728 | $1,275 | 16.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 168 | 172 | $5,676 | $1,136 | 20.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 31 | 85 | $57,722 | $14,058 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 166 | $33,323 | $12,332 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $22,734 | $8,187 | 36.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 35 | $10,761 | $2,688 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 59 | $7,464 | $2,616 | 35.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 210 | 215 | $9,460 | $1,941 | 20.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 211 | 216 | $9,936 | $1,674 | 16.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 213 | 218 | $7,194 | $1,460 | 20.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 39 | 123 | $82,042 | $20,698 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 92 | $17,142 | $6,794 | 39.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $9,943 | $3,693 | 37.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $7,812 | $2,067 | 26.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 46 | $6,083 | $1,965 | 32.3% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 143 | 144 | $6,336 | $1,295 | 20.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 15 | $4,527 | $1,206 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 20 | $4,174 | $1,118 | 26.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 144 | 145 | $6,670 | $1,115 | 16.7% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 148 | 151 | $4,983 | $1,004 | 20.1% |
About Dr. Greg Davis, MD
Dr. Greg Davis, MD is a Internal Medicine healthcare provider based in Brainerd, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619060167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Davis, MD has received a total of $499.72 in payments from pharmaceutical and medical device companies, with $464.10 received in 2023. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($251.61).
As a Medicare-enrolled provider, Davis has provided services to 3,432 Medicare beneficiaries, totaling 3,928 services with total Medicare billing of $171,189. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Brainerd, MN
- Active Since 10/02/2006
- Last Updated 01/07/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619060167
Products in Payments
- ILLUMISITE (Device) $464.10
- IMVEXXY (Drug) $18.80
- Zemaira (Biological) $16.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brainerd
Dr. Eric Fenstad, M.d., Msc, M.D., MSC
Internal Medicine — Payments: $26,972
Daniel Njingeh, Md, MD
Internal Medicine — Payments: $171.20
Daniel Johnson, M.d, M.D
Internal Medicine — Payments: $161.70
Dr. Kendall Fancher, Md, MD
Internal Medicine — Payments: $104.95
James Freeman
Internal Medicine — Payments: $23.36
Dr. Marcy Byrns, Md, MD
Internal Medicine — Payments: $20.51